AstraZeneca introduces next-gen cardiologists through India Coronary Conquest 2026 with STEMI: Our Bureau, Bengaluru Tuesday, April 21, 2026, 15:30 Hrs [IST] AstraZeneca Pharma In ...
Asahi Kasei initiates phase I trial of AK1940, a novel peptide candidate targeting autoimmune diseases: Tokyo Tuesday, April 21, 2026, 15:00 Hrs [IST] Asahi Kasei, a diversified g ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results